55% Covidshield recipients had mild side effects: AMCH study

Credit: IndiaTimes- Published 2 weeks ago

You are here


💡 newsR Knowledge: Other News Mentions

Oxford–AstraZeneca COVID-19 vaccine

Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca
Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The..
Credit: IndiaTimes - Published 2 days ago

You might like